Zobrazeno 1 - 10
of 654
pro vyhledávání: '"Katsumi, Eguchi"'
Autor:
Kanako Tsutsumi, Narumichi Iwamura, Katsumi Eguchi, Ayuko Takatani, Tomohiro Koga, Takeshi Araki, Toshiyuki Aramaki, Kaoru Terada, Yukitaka Ueki
Publikováno v:
Immunological Medicine, Pp 1-10 (2024)
Although rapidly progressive glomerulonephritis (RPGN) is the main renal phenotype of microscopic polyangiitis (MPA), we aim to clarify the clinical features of slowly progressive MPA. This retrospective observational study included 12 patients diagn
Externí odkaz:
https://doaj.org/article/7e13539731b34ae0890bae658da3a850
Autor:
Narumichi Iwamura, Katsumi Eguchi, Tomohiro Koga, Kanako Tsutsumi, Takeshi Araki, Toshiyuki Aramaki, Ayuko Takatani, Kaoru Terada, Yukitaka Ueki
Publikováno v:
Immunological Medicine, Vol 46, Iss 2, Pp 97-107 (2023)
AbstractA 61-year-old man with no previous record of autoimmune disease developed fever, polyarthralgia, purpura, and urticaria-like rash 2 weeks after the first dose of the Moderna mRNA-1273 vaccine, and symptoms deteriorated following the second do
Externí odkaz:
https://doaj.org/article/4afa2e38eacc445dab39df9d013bfe1a
Autor:
Ayuko Takatani, Naoki Iwamoto, Serina Koto, Toshiyuki Aramaki, Kaoru Terada, Yukitaka Ueki, Atsushi Kawakami, Katsumi Eguchi
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundThe SARS-CoV-2 mRNA vaccine has been reported to cause various adverse reactions, including the development or exacerbation of autoimmune diseases, but the adverse reactions and the effects of the vaccines on disease activity in patients wi
Externí odkaz:
https://doaj.org/article/ac25a98b97a247d4888ba8d3ea8a2630
Autor:
Tomoki Origuchi, Masataka Umeda, Tomohiro Koga, Shin-ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Toshiaki Tsukada, Taiichiro Miyashita, Nozomi Iwanaga, Yoshiro Horai, Kazuhiko Arima, Toshiyuki Aramaki, Yukitaka Ueki, Katsumi Eguchi, Atsushi Kawakami
Publikováno v:
Immunological Medicine, Pp 1-7 (2022)
Remitting seronegative symmetrical synovitis with pitting edema syndrome (RS3PE), a rheumatic disease affecting the elderly, responds well to corticosteroids; however, our RS3PE patients' corticosteroid therapy is longer than expected. Elderly-onset
Externí odkaz:
https://doaj.org/article/43b0af4aa16646ff9cd72e591e7bdfc2
Autor:
Naoki Iwamoto, Shuntaro Sato, Shota Kurushima, Toru Michitsuji, Shinya Nishihata, Momoko Okamoto, Yoshika Tsuji, Yushiro Endo, Toshimasa Shimizu, Remi Sumiyoshi, Takahisa Suzuki, Akitomo Okada, Tomohiro Koga, Shin-ya Kawashiri, Keita Fujikawa, Takashi Igawa, Toshiyuki Aramaki, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Akinari Mizokami, Tomoki Origuchi, Yukitaka Ueki, Katsumi Eguchi, Atsushi Kawakami
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-10 (2021)
Abstract Objective To compare the efficacy and safety of tofacitinib and baricitinib in patients with RA in a real-world setting. Methods A total of 242 patients with RA who were treated with tofacitinib (n = 161) or baricitinib (n = 81) were enrolle
Externí odkaz:
https://doaj.org/article/1c8e820079284bae987b8836e8da78f7
Autor:
Naoki Iwamoto, Takeshi Araki, Ayaka Umetsu, Ayuko Takatani, Toshiyuki Aramaki, Kunihiro Ichinose, Kaoru Terada, Naoyuki Hirakata, Yukitaka Ueki, Atsushi Kawakami, Katsumi Eguchi
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectiveWe evaluated changes of HTLV-1 proviral loads (PVLs) during treatment for rheumatoid arthritis (RA) and investigated whether these changes affect the clinical course in HTLV-1-positive RA patients.MethodsA total of 41 HTLV-1-positive RA pati
Externí odkaz:
https://doaj.org/article/6785cf40f29c4bbe9fbef3414b758575
Autor:
Ayaka Umetsu, Katsumi Eguchi, Tomohiro Koga, Takeshi Araki, Ayuko Takatani, Toshiyuki Aramaki, Kaoru Terada, Naoki Iwamoto, Kenji Miyahara, Nobuhisa Yonemitsu, Hideki Nakamura, Atsushi Kawakami, Yukitaka Ueki
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 9, p1305-1309, 5p
Autor:
Tomoyuki Asano, Hiroshi Furukawa, Shuzo Sato, Makiko Yashiro, Hiroko Kobayashi, Hiroshi Watanabe, Eiji Suzuki, Tomoyuki Ito, Yoshifumi Ubara, Daisuke Kobayashi, Nozomi Iwanaga, Yasumori Izumi, Keita Fujikawa, Satoshi Yamasaki, Tadashi Nakamura, Tomohiro Koga, Toshimasa Shimizu, Masataka Umeda, Fumiaki Nonaka, Michio Yasunami, Yukitaka Ueki, Katsumi Eguchi, Naoyuki Tsuchiya, Shigeto Tohma, Koh-ichiro Yoshiura, Hiromasa Ohira, Atsushi Kawakami, Kiyoshi Migita
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-8 (2017)
Abstract Background HLA-DRB1 alleles are major determinants of genetic predisposition to rheumatic diseases. We assessed whether DRB1 alleles are associated with susceptibility to particular clinical features of adult onset Still’s disease (AOSD) i
Externí odkaz:
https://doaj.org/article/22f11a3f59c04a2da7c536aecd0bd257
Autor:
Naoki Iwamoto, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Shoichi Fukui, Masataka Umeda, Ayako Nishino, Yoshiro Horai, Tomohiro Koga, Shin-Ya Kawashiri, Toshiyuki Aramaki, Kunihiro Ichinose, Yasuko Hirai, Mami Tamai, Hideki Nakamura, Kaoru Terada, Tomoki Origuchi, Katsumi Eguchi, Yukitaka Ueki, Atsushi Kawakami
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177057 (2017)
We evaluated the efficacy and safety of tofacitinib in patients with rheumatoid arthritis (RA) in a real-world setting.Seventy consecutive patients, for whom tofacitinib was initiated between November 2013 and May 2016, were enrolled. All patients fu
Externí odkaz:
https://doaj.org/article/a3f3e139d957491abe032249d0cc67ba
Autor:
Tomohiro Koga, Akitomo Okada, Takaaki Fukuda, Toshihiko Hidaka, Tomonori Ishii, Yukitaka Ueki, Takao Kodera, Munetoshi Nakashima, Yuichi Takahashi, Seiyo Honda, Yoshiro Horai, Ryu Watanabe, Hiroshi Okuno, Toshiyuki Aramaki, Tomomasa Izumiyama, Osamu Takai, Taiichiro Miyashita, Shuntaro Sato, Shin-Ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Tomoki Origuchi, Hideki Nakamura, Kiyoshi Aoyagi, Katsumi Eguchi, Atsushi Kawakami, Japanese RA Patients with RRP Study Group
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0175281 (2017)
To determine prognostic factors of clinically relevant radiographic progression (CRRP) in patients with rheumatoid arthritis (RA) achieving remission or low disease activity (LDA) in clinical practice.Using data from a nationwide, multicenter, prospe
Externí odkaz:
https://doaj.org/article/0407a476605f4fc78a30abae49524d09